Automatic segmentation and quantification of nigrosome-1 neuromelanin and iron in MRI: a candidate biomarker for Parkinson’s disease
View ORCID ProfileMikel Ariz, Martín Martínez, Ignacio Alvarez, Maria A. Fernández-Seara, The Catalonian Neuroimaging Parkinson’s disease Consortium, Pau Pastor, Maria A. Pastor, Carlos Ortiz de Solórzano
doi: https://doi.org/10.1101/2023.04.13.23288519
Mikel Ariz
1Ciberonc and Solid Tumours and Biomarkers Program, CIMA University of Navarra, Pamplona, Spain
2Department of Electrical, Electronic and Communications Engineering, Public University of Navarre, Pamplona, Spain
PhDMartín Martínez
3Neuroimaging Laboratory, University of Navarra, School of Medicine, Pamplona, Spain
PhDIgnacio Alvarez
4Movement Disorders Unit, Neurology, University Hospital Mútua de Terrassa, Terrassa, Barcelona, Spain
MScMaria A. Fernández-Seara
5Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain
6IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain
PhDPau Pastor
7Unit of Neurodegenerative diseases, Department of Neurology, University Hospital Germans Trias i Pujol, and Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain
MD, PhDMaria A. Pastor
3Neuroimaging Laboratory, University of Navarra, School of Medicine, Pamplona, Spain
8Movement Disorders Unit, Neurology, University of Navarra
MD, PhDCarlos Ortiz de Solórzano
1Ciberonc and Solid Tumours and Biomarkers Program, CIMA University of Navarra, Pamplona, Spain
6IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain
PhD
Posted April 17, 2023.
Automatic segmentation and quantification of nigrosome-1 neuromelanin and iron in MRI: a candidate biomarker for Parkinson’s disease
Mikel Ariz, Martín Martínez, Ignacio Alvarez, Maria A. Fernández-Seara, The Catalonian Neuroimaging Parkinson’s disease Consortium, Pau Pastor, Maria A. Pastor, Carlos Ortiz de Solórzano
medRxiv 2023.04.13.23288519; doi: https://doi.org/10.1101/2023.04.13.23288519
Automatic segmentation and quantification of nigrosome-1 neuromelanin and iron in MRI: a candidate biomarker for Parkinson’s disease
Mikel Ariz, Martín Martínez, Ignacio Alvarez, Maria A. Fernández-Seara, The Catalonian Neuroimaging Parkinson’s disease Consortium, Pau Pastor, Maria A. Pastor, Carlos Ortiz de Solórzano
medRxiv 2023.04.13.23288519; doi: https://doi.org/10.1101/2023.04.13.23288519
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12604)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (620)
- Oncology (2218)
- Ophthalmology (631)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6818)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)